TheStreet Network:
TheStreet
|
MainStreet
|
BankingMyWay
|
RealMoney
Home
About Stockpickr
|
How to Use
Portfolios
Professional
Warren Buffett
George Soros
T. Boone Pickens
Carl Icahn
» Most-Viewed
» Recently Updated
Stockpickr Spotlight
4 Turnarounds Poised for better days Ahead
Zombie Apocalypse Portfolio
2 Stocks That Will Double in 2013
Less-Volatile Stocks for a Volatile World
5 Small-Cap Bank Stock Plays for 2013 From Credit Suisse
» More Spotlight Portfolios
User Generated
Recently Updated
Tools
Market Indicators
Top % Gainers
Top % Losers
52-Week Highs
52-Week Lows
Rising on Unusual Volume
Unusual Options Activity
Upgrades and Downgrades
Analyst Upgrades
Analyst Downgrades
TheStreet Ratings Upgrades
TheStreet Ratings Downgrades
Daily Lists
Cramer's "Lightning Round"
Insider Buying
Insider Selling
Earnings Announcements
Ex-Dividend Stocks
Dogs of the Dow
Articles
5 Stocks Set to Soar on Bullish Earnings
5 Rocket Stocks Ready for Blastoff
5 Stocks Rising on Unusual Volume
3 Tech Stocks Spiking on Huge Volume
4 Tech Stocks to Trade (or Not)
» More Articles
My Stockpickr
Log In
|
Join for Free
Stock Game
Health Care: Drugs
Synergy Pharmaceuticals Inc. (SGYPD: NASDAQ)
$3.45
-0.06 | -1.71%
01/03/12 - 03:59 PM ET
Quote
Ratings
Earnings
Fundamentals
Options Chain
Advanced Chart
Balance Sheet
Cash Flow
Income Statement
Growth Rates
Major Holders
Ratio Comparison
15.28K / 16.30K
Vol / Avg. Vol:
3.55 / 3.51
Open / Prev. Close:
3.27 - 3.58
Today's Range:
3.17 - 13.98
52 Wk Range:
n/a%
Performance YTD:
No Rating
TheStreet Rating:
Find out if SGYPD is in Cramer's Portfolio
6-MONTH
CHART:
1-Day
|
5-Day
|
1-Month
|
3-Month
|
6-Month
|
1-Year
See Advanced Charting for SGYPD
Portfolios with
SGYPD
Portfolio Name
User Type
View All
Latest
SGYPD
Headlines from TheStreet
More Financial News for SGYPD
Press Releases for
SGYPD
Synergy Pharmaceuticals Announces Full Exercise Of Over-Allotment Option By Aegis Capital Corp.
- Business Wire 12.13.11 | 04:12 pm
Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. And Its Chief Scientific Officer And Senior VP Of R&D, Dr. Mark G. Currie
- PR Newswire 12.13.11 | 08:12 am
Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. And Its Chief Scientific Officer And Senior VP Of R&D, Dr. Mark G. Currie
- Business Wire 12.13.11 | 03:12 am
Synergy Pharmaceuticals Announces Closing Of Public Offering Of 1,875,000 Units
- Business Wire 12.06.11 | 05:12 pm
See All Press Releases
Partner Headlines for
SGYPD
Synergy Pharmaceuticals Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.
- Benzinga 12.13.11 | 04:12 pm
Morning Market Movers
- Benzinga 12.06.11 | 09:12 am
Refresh Stock Quote for Synergy Pharmaceuticals Inc. - SGYPD
'Mad Money' Uncover...
Silver Is Getting P...
The Week Ahead: Hom...
Home
About Stockpickr
How to Use
Join for FREE
STOCK GAME
Portfolios
Professional
Warren Buffett
George Soros
T. Boone Pickens
Carl Icahn
Most-Viewed
Recently Updated
Stockpickr Spotlight
4 Turnarounds Poised for better days Ahead
Zombie Apocalypse Portfolio
2 Stocks That Will Double in 2013
Less-Volatile Stocks for a Volatile World
5 Small-Cap Bank Stock Plays for 2013 From Credit Suisse
More Spotlight Portfolios
User Generated
Recently Updated
Tools
Market Indicators
Top % Gainers
Top % Losers
52-Week Highs
52-Week Lows
Rising on Unusual Volume
Unusual Options Activity
Upgrades and Downgrades
Analyst Upgrades
Analyst Downgrades
TheStreet Ratings Upgrades
TheStreet Ratings Downgrades
Daily Lists
Cramer's "Lightning Round"
Insider Buying
Insider Selling
Earnings Announcements
Ex-Dividend Stocks
Dogs of the Dow
Articles
5 Stocks Set to Soar on Bullish Earnings
5 Rocket Stocks Ready for Blastoff
5 Stocks Rising on Unusual Volume
3 Tech Stocks Spiking on Huge Volume
4 Tech Stocks to Trade (or Not)
More Articles
My Stockpickr
My Stockpickr Profile
Inbox
Add New Portfolio
Edit My Profile